Trigger Finger Preference Elicitation Tool

Does the Use of a Preference Elicitation Tool at Point of Care in Trigger Finger Change Decisional Conflict?

The purpose of this study is to evaluate a patient's level of decisional conflict for their treatment decision regarding their trigger finger, and study if the use of a preference elicitation tool at point of care is able to alter the level of decisional conflict

Study Overview

• Status: Terminated
• Conditions: Trigger Finger; Trigger Finger Disorder; Trigger Thumb; Trigger Digit; Trigger Thumb, Left Thumb; Trigger Thumb, Right Thumb; Trigger Finger, Ring Finger; Trigger Finger, Index Finger; Trigger Finger, Middle Finger; Trigger Finger, Little Finger; Trigger Thumb, Unspecified Thumb; Trigger Finger, Unspecified Finger
• Intervention / Treatment: Other: handout; Other: Preference elicitation tool

Detailed Description

All patients presenting to the Hand Surgery clinic for evaluation of a new trigger finger will be approached for inclusion in the study. Upon diagnosis, a patient diagnosed with a trigger will be informed of the study, asked if they would like to participate, and consented into the study. Patients will then be randomized to a control group versus our test group. The control group will be given a generic handout about trigger finger and the treatment options. They will then complete the decisional conflict survey without using the tool. The second group will use the tool and then complete the decisional conflict survey.

The standard of care is not being altered- all treatment options will still be available to patients and they have select whatever option is most in line with their preference for treatment. The purpose of the tool is to facilitate preference elicitation for treatment.

• Study Type: Interventional
• Enrollment (Actual): 10
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • California
    • Redwood City, California, United States, 94063
      • Stanford Health Care

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• diagnosis of trigger finger

Exclusion Criteria:

• prior trigger finger treatment

Study Plan

How is the study designed?

Design Details

• Primary Purpose: HEALTH_SERVICES_RESEARCH
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: NONE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
ACTIVE_COMPARATOR: Control	Other: handout; handout with information about trigger fingers
EXPERIMENTAL: intervention- tool	Other: Preference elicitation tool; Ranking tool to assess patient preferences for trigger finger treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Decisional Conflict Scale (DCS)	Decisional Conflict Scale (DCS) is a validated tool that measures a state of uncertainty about a course of action. DCS is a 16 item scale, scores range from 0-100, with higher scores indicating greater decisional conflict	Immediately after visit

Collaborators and Investigators

• Sponsor: Stanford University
• Investigators: Principal Investigator: Robin Kamal, Stanford University

Study record dates

Study Major Dates

• Study Start (ACTUAL): March 20, 2019
• Primary Completion (ACTUAL): July 1, 2021
• Study Completion (ACTUAL): July 1, 2021

Study Registration Dates

• First Submitted: April 8, 2019
• First Submitted That Met QC Criteria: April 8, 2019
• First Posted (ACTUAL): April 10, 2019

Study Record Updates

• Last Update Posted (ACTUAL): November 12, 2021
• Last Update Submitted That Met QC Criteria: November 5, 2021
• Last Verified: November 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Musculoskeletal Diseases; Muscular Diseases; Tendinopathy; Tendon Entrapment; Trigger Finger Disorder
• Other Study ID Numbers: 45990

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No